Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar naughtyguy (65.17) Submitted: 8/19/2011 1:40:45 PM : Underperform Start Price: $50.72 ALXN Score: -65.04

9 times book value!

Featured Broker Partners


Advertisement